Kronos Bio (KRON) Short Interest Ratio & Short Volume $0.69 +0.00 (+0.29%) As of 05/23/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kronos Bio Short Interest DataKronos Bio (KRON) has a short interest of 671,400 shares, representing 1.71% of the float (the number of shares available for trading by the public). This marks a 0.30% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 308,364 shares to cover all short positions.Current Short Interest671,400 sharesPrevious Short Interest669,400 sharesChange Vs. Previous Month+0.30%Dollar Volume Sold Short$599,425.92Short Interest Ratio1.9 Days to CoverLast Record DateApril 30, 2025Outstanding Shares60,969,000 sharesFloat Size39,230,000 sharesShort Percent of Float1.71%Today's Trading Volume425,932 sharesAverage Trading Volume308,364 sharesToday's Volume Vs. Average138% Short Selling Kronos Bio? Sign up to receive the latest short interest report for Kronos Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKRON Short Interest Over TimeKRON Days to Cover Over TimeKRON Percentage of Float Shorted Over Time Kronos Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025671,400 shares $599,425.92 +0.3%1.7%1.9 $0.89 4/15/2025669,400 shares $581,039.20 +9.5%1.7%4 $0.87 3/31/2025611,600 shares $504,570.00 -18.2%1.6%3.3 $0.83 3/15/2025748,000 shares $703,120.00 -13.4%1.9%3.2 $0.94 2/28/2025863,500 shares $846,230.00 -5.9%2.2%3.3 $0.98 2/15/2025918,000 shares $936,360.00 -2.1%2.4%3.1 $1.02 1/31/2025937,500 shares $946,875.00 +63.1%2.4%3 $1.01 1/15/2025574,800 shares $563,304.00 -0.5%1.5%2 $0.98 12/31/2024577,700 shares $548,815.00 +16.5%1.5%2.3 $0.95 12/15/2024496,000 shares $486,030.40 -1.1%1.3%2.6 $0.98 Get the Latest News and Ratings for KRON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kronos Bio and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024501,300 shares $476,235.00 -3.8%1.3%2.8 $0.95 11/15/2024521,000 shares $442,850.00 -1.3%1.4%4.5 $0.85 10/31/2024527,700 shares $511,869.00 -21.8%1.3%6.4 $0.97 10/15/2024674,500 shares $647,520.00 -5.6%1.7%7.7 $0.96 9/30/2024714,200 shares $714,128.58 -4.6%1.8%5.9 $1.00 9/15/2024748,400 shares $710,979.25 -1.3%1.9%4.9 $0.95 8/31/2024758,500 shares $796,425.00 +7.7%1.9%2.5 $1.05 8/15/2024704,500 shares $695,764.20 -2.0%1.8%2 $0.99 7/31/2024718,500 shares $934,050.00 -7.8%1.9%1.9 $1.30 7/15/2024779,500 shares $1.12 million +8.2%2.0%1.5 $1.44 6/30/2024720,200 shares $893,048.00 -0.5%1.9%1.4 $1.24 6/15/2024723,500 shares $781,380.00 +5.0%1.9%1.5 $1.08 5/31/2024688,800 shares $544,152.00 -3.5%1.6%1.6 $0.79 5/15/2024714,100 shares $700,817.74 +4.0%1.7%1.6 $0.98 4/30/2024686,800 shares $707,404.00 +3.6%1.7%1.7 $1.03 4/15/2024662,700 shares $755,478.00 -0.4%1.7%1.9 $1.14 3/31/2024665,000 shares $864,500.00 -0.4%1.7%2.6 $1.30 3/15/2024667,800 shares $774,648.00 +11.2%1.7%2.7 $1.16 2/29/2024600,400 shares $624,416.00 -1.8%1.6%2.3 $1.04 2/15/2024611,600 shares $660,528.00 +2.3%1.6%4.1 $1.08 1/31/2024597,700 shares $675,401.00 -74.9%1.6%2.9 $1.13 1/15/20242,380,000 shares $2.81 million -0.4%6.3%10.9 $1.18 12/31/20232,390,000 shares $2.99 million -1.7%6.3%8.8 $1.25 12/15/20232,430,000 shares $3.62 million -10.7%6.4%8.8 $1.49 11/30/20232,720,000 shares $3.24 million -0.4%7.2%10.5 $1.19 11/15/20232,730,000 shares $2.48 million +0.4%7.3%10.6 $0.91 10/31/20232,720,000 shares $2.38 million -1.8%7.0%14 $0.87 10/15/20232,770,000 shares $2.75 million -0.7%7.2%15 $0.99 9/30/20232,790,000 shares $3.63 million -2.1%7.2%18.4 $1.30 9/15/20232,850,000 shares $3.51 million +0.7%7.4%10.7 $1.23Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 8/31/20232,830,000 shares $3.93 million No Change7.4%10 $1.39 8/15/20232,830,000 shares $4.67 million -1.4%7.4%9.4 $1.65 7/31/20232,870,000 shares $5.51 million -0.7%7.6%9.1 $1.92 7/15/20232,890,000 shares $6.01 million -13.2%7.6%7.1 $2.08 6/30/20233,330,000 shares $5.73 million -21.5%8.7%7.9 $1.72 6/15/20234,240,000 shares $7.21 million +5.2%11.0%10.5 $1.70 5/31/20234,030,000 shares $6.73 million +0.8%10.5%12.7 $1.67 5/15/20234,000,000 shares $7.48 million -5.0%10.4%12.6 $1.87 4/30/20234,210,000 shares $6.95 million -1.9%11.0%13.1 $1.65 4/15/20234,290,000 shares $5.58 million +3.6%11.2%14 $1.30 3/31/20234,140,000 shares $6.04 million +10.4%10.9%13.9 $1.46 3/15/20233,750,000 shares $5.63 million +7.5%9.9%12.3 $1.50 2/28/20233,490,000 shares $6.07 million +0.6%9.3%11.5 $1.74 2/15/20233,470,000 shares $7.25 million +1.2%9.3%11.6 $2.09 1/31/20233,430,000 shares $8.23 million -3.7%9.0%12 $2.40 1/15/20233,560,000 shares $9.33 million -0.3%9.4%13.6 $2.62 12/30/20223,570,000 shares $5.78 million -0.8%9.4%15.5 $1.62 12/15/20223,600,000 shares $6.66 million +1.7%9.5%18.7 $1.85 11/30/20223,540,000 shares $6.73 million -2.2%9.3%20.9 $1.90 11/15/20223,620,000 shares $8.65 million -1.4%9.5%20.3 $2.39 10/31/20223,670,000 shares $10.86 million No Change9.3%19.8 $2.96 10/15/20223,670,000 shares $10.42 million -0.3%9.3%17.1 $2.84 9/30/20223,680,000 shares $12.33 million +0.6%9.4%16.2 $3.35 9/15/20223,660,000 shares $17.53 million +3.7%9.3%14.1 $4.79 8/31/20223,530,000 shares $14.12 million +4.1%9.0%10.2 $4.00 8/15/20223,390,000 shares $17.49 million -3.7%8.6%8.3 $5.16 7/31/20223,520,000 shares $14.78 million -9.0%9.0%6.9 $4.20 7/15/20223,870,000 shares $19.12 million -3.7%9.8%7.5 $4.94 6/30/20224,020,000 shares $14.63 million -14.5%10.2%7.7 $3.64 6/15/20224,700,000 shares $15.75 million +2.2%11.9%9 $3.35 5/31/20224,600,000 shares $17.11 million +4.3%11.7%10.4 $3.72 5/15/20224,410,000 shares $17.24 million +2.8%11.0%11.3 $3.91 4/30/20224,290,000 shares $20.29 million +2.4%12.0%13.2 $4.73 4/15/20224,190,000 shares $24.68 million -3.5%11.7%13.8 $5.89 3/31/20224,340,000 shares $31.38 million -5.7%12.2%14.3 $7.23 3/15/20224,600,000 shares $32.84 million -0.9%12.9%15.2 $7.14 2/28/20224,640,000 shares $34.94 million +6.2%13.0%14.1 $7.53 2/15/20224,370,000 shares $30.94 million -6.4%12.1%12.5 $7.08 1/31/20224,670,000 shares $42.50 million -2.3%12.9%15.5 $9.10 1/15/20224,780,000 shares $51.05 million -11.3%13.2%17.3 $10.68 12/31/20215,390,000 shares $73.25 million +2.9%14.9%20.4 $13.59 12/15/20215,240,000 shares $70.79 million +3.8%14.5%19.6 $13.51 11/30/20215,050,000 shares $59.64 million +3.9%13.9%22.5 $11.81 11/15/20214,860,000 shares $81.41 million +10.7%13.4%22.4 $16.75 10/29/20214,390,000 shares $72.26 million +1.6%12.1%21.9 $16.46 10/15/20214,320,000 shares $72.49 million +0.2%11.9%22.9 $16.78 9/30/20214,310,000 shares $90.34 million +5.4%11.9%22.3 $20.96 9/15/20214,090,000 shares $98.08 million -2.2%11.3%16 $23.98 8/31/20214,180,000 shares $87.40 million -5.0%11.5%15 $20.91 8/13/20214,400,000 shares $88.44 million No Change12.1%15.4 $20.10Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 7/30/20214,400,000 shares $89.98 million -9.7%12.2%15.1 $20.45 7/15/20214,870,000 shares $99.45 million -2.6%13.5%16.4 $20.42 6/30/20215,000,000 shares $119.75 million +12.6%13.9%16.6 $23.95 6/15/20214,440,000 shares $114.06 million +3.5%12.3%16.4 $25.69 5/28/20214,290,000 shares $104.72 million +6.2%11.9%17.3 $24.41 5/14/20214,040,000 shares $102.49 million +6.0%11.2%18.5 $25.37 4/30/20213,810,000 shares $96.96 million -2.8%10.6%18.6 $25.45 4/15/20213,920,000 shares $86.28 million +21.4%11.7%19.6 $22.01 3/31/20213,230,000 shares $89.96 million +18.3%9.7%17.8 $27.85 3/15/20212,730,000 shares $78.27 million +22.4%8.2%13.4 $28.67 2/26/20212,230,000 shares $65.00 million +1.8%6.7%12.5 $29.15 2/12/20212,190,000 shares $65.92 million +7.9%6.6%12.3 $30.10 1/29/20212,030,000 shares $55.48 million +0.5%6.0%10.4 $27.33 1/15/20212,020,000 shares $64.56 million No Change6.0%9.7 $31.96 KRON Short Interest - Frequently Asked Questions What is Kronos Bio's current short interest? Short interest is the volume of Kronos Bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 671,400 shares of KRON short. 1.71% of Kronos Bio's shares are currently sold short. Learn More on Kronos Bio's current short interest. What is a good short interest ratio for Kronos Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRON shares currently have a short interest ratio of 2.0. Learn More on Kronos Bio's short interest ratio. What is a good short interest percentage for Kronos Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.71% of Kronos Bio's floating shares are currently sold short. Is Kronos Bio's short interest increasing or decreasing? Kronos Bio saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 671,400 shares, an increase of 0.3% from the previous total of 669,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Kronos Bio's float size? Kronos Bio currently has issued a total of 60,969,000 shares. Some of Kronos Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kronos Bio currently has a public float of 39,230,000 shares. How does Kronos Bio's short interest compare to its competitors? 1.71% of Kronos Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kronos Bio: INmune Bio, Inc. (25.37%), Tiziana Life Sciences Ltd (1.32%), Molecular Partners AG (0.14%), Eledon Pharmaceuticals, Inc. (2.99%), Organigram Holdings Inc. (8.03%), Inhibrx, Inc. (7.27%), ProQR Therapeutics (0.36%), DiaMedica Therapeutics Inc. (1.45%), AC Immune SA (2.25%), Esperion Therapeutics, Inc. (15.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Kronos Bio stock? Short selling KRON is an investing strategy that aims to generate trading profit from Kronos Bio as its price is falling. KRON shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kronos Bio? A short squeeze for Kronos Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KRON, which in turn drives the price of the stock up even further. How often is Kronos Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRON, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies INmune Bio Short Interest Data Tiziana Life Sciences Short Interest Data Molecular Partners Short Interest Data Eledon Pharmaceuticals Short Interest Data Organigram Short Interest Data Inhibrx Short Interest Data ProQR Therapeutics Short Interest Data DiaMedica Therapeutics Short Interest Data AC Immune Short Interest Data Esperion Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRON) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kronos Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kronos Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KRON Stock Free KRON Stock Alerts